Table 2:
Operative data (N = 462)a,b
| Procedure | Overall series |
PS-matched pairs |
||||
|---|---|---|---|---|---|---|
| B-TVA (N = 345) |
R-TVA (N = 117) |
P-value | B-TVA (N = 98) |
R-TVA (N = 98) |
P-value | |
| Tricuspid valve annuloplasty | ||||||
| Band | ||||||
| Medtronic-Duran®c | 66 (19.1) | – | 16 (16.3) | – | ||
| Koehler mrs®d | 98 (28.4) | – | 26 (26.5) | – | ||
| CarboMedics Annulo Flex®e | 181 (52.5) | – | 56 (57.1) | – | ||
| Ring | ||||||
| Carpentier–Edwards Classic®f | – | 25 (21.4) | – | 23 (23.5) | ||
| Edwards MC3®f | – | 24 (20.5) | – | 22 (22.4) | ||
| Carpentier–Edwards Physio®f | – | 68 (58.1) | – | 53 (54.1) | ||
| Annuloplasty device size, mm | 32 ± 2.1 | 31.8 ± 2.4 | 0.39 | 31.7 ± 2 | 31.9 ± 2.3 | 0.52 |
| Concomitant procedure | ||||||
| Mitral valve surgery | 310 (89.9) | 105 (89.7) | 1 | 84 (85.7) | 90 (91.8) | 0.17 |
| Aortic valve surgery | 109 (31.6) | 39 (33.3) | 0.73 | 39 (39.8) | 28 (28.6) | 0.098 |
| Thoracic aortic surgery | 14 (4.1) | 6 (5.1) | 0.62 | 6 (6.1) | 5 (5.1) | 0.75 |
| Coronary bypass surgery | 96 (27.8) | 35 (29.9) | 0.66 | 23 (23.5) | 29 (29.6) | 0.33 |
| LV reconstruction | 4 (1.2) | 0 | 0.31 | 0 | 0 | – |
| Cryosurgical ablation for atrial fibrillation | 67/110 (60.9) | 14/30 (46.7) | 0.16 | 17/30 (56.7) | 14/28 (50) | 0.61 |
| Pacemaker implantation and lead placing | 6 (1.7) | 5 (4.3) | 0.16 | 2 (2) | 3 (3.1) | 1 |
| Atrial septal defect closure | 3 (0.9) | 2 (1.7) | 0.6 | 1 (1) | 2 (2) | 1 |
| Otherg | 14 (4.1) | 3 (2.6) | 0.58 | 4 (4.1) | 2 (2) | 0.68 |
| Aortic cross-clamping time, min | 125 ± 38 | 125 ± 37 | 0.98 | 125 ± 42 | 124 ± 36 | 0.85 |
| Use of Custodiol-HTK® solutionh | 143 (41.4) | 67 (57.3) | 0.003 | 42 (42.9) | 52 (53.1) | 0.15 |
| Cardiopulmonary bypass time, min | 164 ± 51 | 173 ± 54 | 0.095 | 161 ± 55 | 172 ± 53 | 0.17 |
| Duration of surgery, min | 308 ± 90 | 327 ± 96 | 0.051 | 299 ± 91 | 323 ± 94 | 0.068 |
B-TVA: band tricuspid valve annuloplasty; HTK: histidine–tryptophan–ketoglutarate; PS: propensity score; R-TVA: ring tricuspid valve annuloplasty; SD: standard deviation; LV: left ventricular.
aValues are the number of patients with percentages in brackets or mean ± SD.
bData were compared using the χ2 or Fisher's exact test for dichotomous variables, and the Student's t-test for continuous variables. The matched and unmatched patients were compared with paired or unpaired test, respectively.
cMedtronic, Minneapolis, MN, USA.
dKoehler, Bellshill, Scotland.
eSorin-CarboMedics, Austin, TX, USA.
fEdwards Lifesciences, Irvine, CA, USA.
gPatent foramen ovale closure = 3, septal myectomy = 2, pericardiectomy = 3, pulmonic valve replacement = 1, coronary fistula ligature = 1, femoral–femoral bypass = 2, carotid endarterectomy = 2, mastectomy = 1, splenectomy = 1 and right hemicolectomy = 1.
hEssential Pharma, Newtown, PA, USA.